For research use only. Not for therapeutic Use.
Midaglizole（Cat No.:I032265）is a small molecule compound under investigation for its potential therapeutic applications, particularly in the field of immunology. It is designed to modulate the immune response by targeting specific receptors or enzymes involved in the activation or suppression of immune cells. Midaglizole has shown promise in preclinical studies for its ability to regulate immune responses, potentially offering therapeutic benefits in conditions such as autoimmune diseases, chronic inflammation, and transplant rejection. Ongoing research aims to assess its safety, efficacy, and pharmacokinetics, as well as its potential for clinical use in immunotherapy.
| Catalog Number | I032265 |
| CAS Number | 66529-17-7 |
| Synonyms | 2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine |
| Molecular Formula | C16H17N3 |
| Purity | ≥95% |
| IUPAC Name | 2-[2-(4,5-dihydro-1H-imidazol-2-yl)-1-phenylethyl]pyridine |
| InChI | InChI=1S/C16H17N3/c1-2-6-13(7-3-1)14(12-16-18-10-11-19-16)15-8-4-5-9-17-15/h1-9,14H,10-12H2,(H,18,19) |
| InChIKey | TYZQFNOLWJGHRZ-UHFFFAOYSA-N |
| SMILES | C1CN=C(N1)CC(C2=CC=CC=C2)C3=CC=CC=N3 |
